Jamieson et al. 3 reviewed confirmed or probable cases of H1N1 influenza virus infection in pregnant women that were reported to the US Center for Disease Control and Prevention in the spring of 2009. The authors identified a total of 34 cases of pandemic H1N1 in pregnant women from 13 different states between 15 April to 18 May 2009. These cases represented 0.62% of all cases of H1N1 infection identified in the USA in the same timeframe. They estimated an overall incidence of one case per 100,000 pregnant women in the USA during this period. The majority of these women were previously healthy. Three (9%) women presented in the first trimester, 19 (56%) in the second and nine (26%) in the third trimester. Their presentation did not appear to differ from that seen in the general population except for a slight increase in the presence of shortness of breath. Despite the similar presentations, 11 (32%) of these 34 women were admitted to hospital. This is more than four times the rate of hospitalization for H1N1 infection than was seen in the general population during the same period (0.32 per 100,000 pregnant women, 95% confidence interval [CI] 0.13 -0.52 versus 0.076 per 100,000 population at risk, 95% CI 0.07-0.09) and suggests either more severe disease in pregnant patients or greater caution on the part of the clinicians caring for pregnant patients.
Of greater concern is the authors' finding that of the 45 deaths in the USA attributed to H1N1 between 15 April and 16 June 2009, 13% (6) were in pregnant women -13 times higher than would be expected based on the prevalence of pregnancy in the general population. All of the mothers who died had developed pneumonia and subsequent acute respiratory distress syndrome requiring mechanical ventilation. Four of these women were in the third trimester. Five had living children by cesarean delivery and one had fetal loss at the time of maternal death at 11 weeks gestation. None of the infants born to infected mothers showed evidence of infection. influenza infection in the USA during a similar but longer period in the spring of 2009. Almost half of these patients were under the age of 18 years and more than one-third were between the ages of 18 and 49 years. Most had normal chest X-rays and white blood cell counts on presentation. In addition to the typical features of influenza, 39% of patients had diarrhoea or vomiting, 25% of patients were admitted to the intensive care unit and a total of 7% died. The only variable that was associated with a positive outcome was the receipt of antiviral drugs within two days of the onset of illness.
Of Jain et al.'s 272 patients, 18 (7%) were pregnant -a prevalence that is seven times higher than that expected in the general population. Only six of the pregnant patients (33%) had another underlying medical condition (asthma in 4 patients and diabetes in 2 patients). Of the 18 pregnant patients, two (11%) were in the first trimester, three (17%) were in the second trimester and 12 (67%) were in the third trimester. Three of the 18 infected pregnant women died (16%) as compared with 16 of the 254 (6%) non-pregnant patients.
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The Australian and New Zealand Intensive Care study group show similar findings from the perspective of the intensivist. 5 They describe 722 patients admitted to intensive care units in Australia and New Zealand over the period of 1 June to 31 August 2009. This number represents an incidence of intensive care unit (ICU) admission for 2009 H1N1 influenza of 28.1 per million inhabitants and is 15 times the number of ICU admissions due to viral pneumonitis seen in recent years in these countries. In all, 92.7% of the patients were under the age of 65 and 31.7% had no known predisposing factor. The median length of stay for these patients in the ICU was seven days. Of all patients, 14.3% died. The authors report a peak in ICU admissions due to influenza approximately four weeks after the infection becomes widespread in a region and that the increase in ICU patient volume continues for several weeks after this peak.
As was seen in the report by Jamieson et al., pregnant women composed a disproportionate share of the patients admitted to the ICU with H1N1. In all, 9.1% of the patients admitted to the ICU over the study period with H1N1 infection were pregnant. This number is nine times what would be expected based on the prevalence of pregnancy in the general population and again suggests that pregnant women are at increased risk for severe disease after contracting influenza A H1N1.
CONCLUSIONS
What are the implications of these data for practitioners caring for women with influenza-like illness during pregnancy? The data offer additional confirmation that symptomatic influenza and particularly H1N1 infection appears to be both more common in pregnant women and more severe in its manifestations. What remains unclear from these data-sets is how much the disproportionate number of pregnant women with H1N1 infection (severe and otherwise) is due to an increase in pregnancy susceptibility to the virus and how much is due to physician behaviour. Clinicians believing that pregnant women are more at risk of and from influenza than other populations may be more likely to test pregnant patients with influenza-like illness for H1N1 and subsequently admit them to either the hospital or an ICU environment. Data directly comparing the severity of illness in pregnant and non-pregnant patients admitted to hospital or ICU with H1N1 may help clarify the relative contribution of biology and clinician practice. However, while clinical practice may offer some explanation for increased admissions to hospitals or ICUs, it is unlikely to account for the high death rate among pregnant women that has been reported in two of these studies. Therefore, clinicians are well advised to follow the US CDC recommendations to encourage all pregnant women to be vaccinated against both seasonal influenza and H1N1. Clinicians should also follow their recommendations to treat pregnant patients with influenza-like illness early with antiviral agents despite the relative paucity of human pregnancy safety data for these agents. 6 
